<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04333238</url>
  </required_header>
  <id_info>
    <org_study_id>IRB00117171</org_study_id>
    <nct_id>NCT04333238</nct_id>
  </id_info>
  <brief_title>Notation Optimization Through Template Engineering</brief_title>
  <acronym>NOTE</acronym>
  <official_title>Notation Optimization Through Template Engineering</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Johns Hopkins University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized non-blinded controlled trial of a standard note template versus a
      redesigned note template using a simulated patient encounter and the electronic medical
      record.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Residents documented the simulated patient encounter using one of two templates. The standard
      template was based on the usual outpatient progress note. The new template placed the
      assessment and plan section in the beginning, grouped subjective data into the assessment
      section, and deemphasized elements not related to the current presentation.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 20, 2017</start_date>
  <completion_date type="Actual">December 1, 2018</completion_date>
  <primary_completion_date type="Actual">April 26, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Note length</measure>
    <time_frame>Duration of note entry, up to 2 hours</time_frame>
    <description>Note length in line count.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Time to note completion</measure>
    <time_frame>Duration of note entry, up to 2 hours</time_frame>
    <description>Time to note completion in minutes.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Note evaluation by authors using a likert scale</measure>
    <time_frame>Immediately after note entry, up to 1 hour</time_frame>
    <description>Likert-scale survey instrument evaluating perceived organization, structure, and efficiency of note.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Note evaluation by reviewers using the Physician Documentation Quality Instrument</measure>
    <time_frame>Within 1 year</time_frame>
    <description>Physician Documentation Quality Instrument (PDQI-9) - validated note quality scale composed of 9 metrics. 1 is not at all. 5 is extremely.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">36</enrollment>
  <condition>Clinical Documentation</condition>
  <arm_group>
    <arm_group_label>Standard template</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Usual outpatient progress note with standard Subjective Objective Assessment Plan (SOAP) format</description>
  </arm_group>
  <arm_group>
    <arm_group_label>New template</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The assessment and plan section is placed in the beginning, subjective data grouped into the assessment section, and elements not related to the current presentation were deemphasized</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>New progress note template</intervention_name>
    <description>Residents assigned to document with new progress note template</description>
    <arm_group_label>New template</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard progress note template</intervention_name>
    <description>Residents assigned to document with standard progress note template</description>
    <arm_group_label>Standard template</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Residents who had open visit slots during their outpatient clinic time

        Exclusion Criteria:

          -  None
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jeremy A Epstein, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Johns Hopkins University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Johns Hopkins Outpatient Center</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21287</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>March 29, 2020</study_first_submitted>
  <study_first_submitted_qc>April 2, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 3, 2020</study_first_posted>
  <last_update_submitted>April 2, 2020</last_update_submitted>
  <last_update_submitted_qc>April 2, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 6, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Progress note</keyword>
  <keyword>Note template</keyword>
  <keyword>Electronic medical record</keyword>
  <keyword>Note quality</keyword>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>There is no sensitive or protected information. I am able to share any aspect of this trial to whomever would like to know more.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

